KNIGHT CAPITOL CONSULTANTS for GENZYME CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Intellectual Property Issues Affecting the Biotech Industry - S. 515/H.R. 1260) (Patent Reform)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | — |
Medicare/Medicaid MMM
Reimbursement of drugs for renal patients -America's Healthy Future Act (S.____), America's Affordable Health Choices Act (H.R. 3200) Physician Payments Sunshine Act (S. 301)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | — |
Health Issues HCR
Health care reform legislation, and particularly issues of interest to the biotech industry, including follow-on biologics, comparative effectiveness, and import safety -Affordable Health Choices Act (S. 1679); America's Healthy Future Act (S. ___) and America's Affordable Health Choices Act (H.R. 3200)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Prof Staff, House Appropriations Cmte |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.